The future of engineered immune cell therapies.
The future of engineered immune cell therapies.
复制标题
DOI:
10.1126/science.abq6990
复制
发表时间:
2022-11-25
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Immune cells are being engineered to recognize and respond to disease states, acting as a “living drug” when transferred into patients. Therapies based on engineered immune cells are now a clinical reality, with multiple engineered T cell therapies approved for treatment of hematologic malignancies. Ongoing preclinical and clinical studies are testing diverse strategies to modify the fate and function of immune cells for applications in cancer, infectious disease, and beyond. We discuss current progress in treating human disease with immune cell therapeutics, emerging strategies for immune cell engineering, and challenges facing the field, with a particular emphasis on the treatment of cancer, where the most effort has been applied to date.
登录
查看更多内容
影响因子:
14.8
作者:
Chang ZL;Lorenzini MH;Chen X;Tran U;Bangayan NJ;Chen YY
通讯作者:
Chen YY
影响因子:
17.1
作者:
Jan M;Scarfò I;Larson RC;Walker A;Schmidts A;Guirguis AA;Gasser JA;Słabicki M;Bouffard AA;Castano AP;Kann MC;Cabral ML;Tepper A;Grinshpun DE;Sperling AS;Kyung T;Sievers QL;Birnbaum ME;Maus MV;Ebert BL
通讯作者:
Ebert BL
影响因子:
82.9
作者:
Cordoba S;Onuoha S;Thomas S;Pignataro DS;Hough R;Ghorashian S;Vora A;Bonney D;Veys P;Rao K;Lucchini G;Chiesa R;Chu J;Clark L;Fung MM;Smith K;Peticone C;Al-Hajj M;Baldan V;Ferrari M;Srivastava S;Jha R;Arce Vargas F;Duffy K;Day W;Virgo P;Wheeler L;Hancock J;Farzaneh F;Domning S;Zhang Y;Khokhar NZ;Peddareddigari VGR;Wynn R;Pule M;Amrolia PJ
通讯作者:
Amrolia PJ
影响因子:
9.3
作者:
Dannenfelser R;Allen GM;VanderSluis B;Koegel AK;Levinson S;Stark SR;Yao V;Tadych A;Troyanskaya OG;Lim WA
通讯作者:
Lim WA
DOI:
10.1038/s41577-019-0269-6
发表时间:
2020-05
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
Irvine DJ;Dane EL
通讯作者:
Dane EL